Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells
© Filippi-Chiela et al.; licensee BioMed Central Ltd. 2013
Received: 16 December 2012
Accepted: 19 March 2013
Published: 22 March 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|16 Dec 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|16 Jan 2013||Reviewed||Reviewer Report - Renata Cozzi|
|19 Jan 2013||Reviewed||Reviewer Report - Enrique Castellon|
|14 Feb 2013||Author responded||Author comments - Guido Lenz|
|Resubmission - Version 3|
|14 Feb 2013||Submitted||Manuscript version 3|
|27 Feb 2013||Reviewed||Reviewer Report - Renata Cozzi|
|11 Mar 2013||Reviewed||Reviewer Report - Enrique Castellon|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|19 Mar 2013||Editorially accepted|
|22 Mar 2013||Article published||10.1186/1471-2407-13-147|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.